SUN KWANG CO.,Ltd. (KOSDAQ:003100)

Market Cap	123.72B
Revenue (ttm)	188.47B
Net Income (ttm)	30.54B
Shares Out	6.29M
EPS (ttm)	5,035.84
PE Ratio	3.91
Forward PE	n/a
Dividend	400.00 (2.03%)
Ex-Dividend Date	Dec 27, 2024

Volume	8,545
Average Volume	20,226
Open	19,740
Previous Close	19,730
Day's Range	19,250 - 19,740
52-Week Range	14,170 - 23,200
Beta	0.38
RSI	43.59
Earnings Date	Aug 14, 2025

About Revance Therapeutics

SUN KWANG CO.,Ltd. engages in the provision of logistics services in South Korea. The company operates grain and container terminals; provides stevedoring services for automobiles, bulk cargo, timber, general goods, and car ferry CY/CFS primarily in the Incheon, Gunsan, North Port, and Pyeongtaek and Dangjin port terminals; and freight transportation services for general goods, timber, wood, metal, containers, and other various types of cargo. It is also involved in the provision of inland freight and heavy transportation services, including th...

• Industry: Marine Shipping
• Sector: Industrials
• Founded: 1948
• Employees: 240
• Stock Exchange: KOSDAQ
• Ticker Symbol: 003100

Financial Performance

In 2024, SUN KWANG CO.,Ltd.'s revenue was 186.75 billion, an increase of 0.78% compared to the previous year's 185.30 billion. Earnings were 28.48 billion, a decrease of -4.45%.